Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q2 2022 · 10-Q
Revenue$35.84M$35.84M+12.5% vs Q2 2021 Net Income$3.72M$3.72M+38.9% vs Q2 2021 EPS Diluted$0.70$0.70+37.3% vs Q2 2021 Gross Profit$23,140,000+8.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flowderived$4,434,000−57.9% Free Cash Flowderived$3,496,000−65.2% Margins · derivedGross margin64.6%−2.2 pt vs Q2 2021
Operating margin11.7%−2.3 pt vs Q2 2021
Net margin10.4%+2.0 pt vs Q2 2021
ended Sep 30, 2021 · filed Nov 4, 2021 · 35 d after period end